Trademark: 79188687
Word
OPIS
Status Date
Tuesday, June 12, 2018
Registration Number
5488596
Registration Date
Tuesday, June 12, 2018
Filing Date
Monday, February 22, 2016
Published for Opposition
Tuesday, March 27, 2018
35 Business consulting in the fields of clinical research and health research; Regulatory submission management for the pharmaceutical and biotechnology industries, namely, assisting others in preparing and filing applications for clinical trial approval, pharmaceutical and health product approval
42 Research and development in the medical, pharmaceutical and biotechnological fields, namely, Pharmaceutical research and development, Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical products development; Conducting and monitoring clinical trials for pharmaceutical products, namely, conducting clinical trials for others, monitoring pharmaceutical clinical trials for others for quality control purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a searchable database in the fields of medical, pharmaceutical and biotechnological research; Database development services for others to process data collected from clinical trials; Pharmacovigilance, namely, monitoring pharmaceutical clinical trials for others for quality control purposes, conducting quality evaluation and analysis, quality assurance, and quality control testing for others in the pharmaceutical field; Toxicology services; Contract research organization services for pharmaceutical development and clinical development and trial, namely, conducting clinical trials for others; designing and developing software for others for use in managing data in the medical, pharmaceutical and biotechnological industries
The mark consists of the stylized word "OPIS" wherein the center of the letter "O" has a stylized human face. The color dark blue appears in the letters "OPIS" as well as the depiction of the eye located on the light blue side of the human face that is closest to the letter "P". The color light blue appears in the right half of the human face. The color blue appears in the left half of the stylized human face. The color white appears in the depiction of the eye located on the blue side of the human face. Other than the color white appearing in the eye, the color white represents background, outlining, shading, and/or transparent areas and are not part of the mark.
The color(s) white, blue, light blue and dark blue is/are claimed as a feature of the mark.
Jul 13, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Jul 7, 2016
Sn Assigned For Sect 66a Appl From Ib
Jul 8, 2016
New Application Office Supplied Data Entered
Jul 8, 2016
Assigned To Examiner
Jul 12, 2016
Application Filing Receipt Mailed
Jul 12, 2016
Non-Final Action Written
Feb 22, 2017
Final Refusal E-Mailed
Jul 13, 2016
Refusal Processed By Mpu
Jul 13, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Jul 29, 2016
Refusal Processed By Ib
Dec 21, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 21, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 13, 2017
Teas Response To Office Action Received
Jan 13, 2017
Correspondence Received In Law Office
Jan 14, 2017
Teas/Email Correspondence Entered
Feb 22, 2017
Final Refusal Written
Feb 22, 2017
Notification Of Final Refusal Emailed
Dec 13, 2017
Notification Of Possible Opposition Sent To Ib
Apr 27, 2017
New Representative At Ib Received
Aug 17, 2017
Subsequent Final Refusal Written
Aug 17, 2017
Subsequent Final Emailed
Aug 17, 2017
Notification Of Subsequent Final Emailed
Sep 5, 2017
Subsequent Final Refusal Written
Sep 5, 2017
Subsequent Final Emailed
Sep 5, 2017
Notification Of Subsequent Final Emailed
Dec 13, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 7, 2018
Notification Of Notice Of Publication E-Mailed
Mar 27, 2018
Published For Opposition
Jan 18, 2018
Notification Of Possible Opposition - Processed By Ib
Jan 24, 2018
Examiners Amendment -Written
Jan 24, 2018
Examiners Amendment E-Mailed
Jan 24, 2018
Notification Of Examiners Amendment E-Mailed
Jan 24, 2018
Examiner's Amendment Entered
Feb 15, 2018
Approved For Pub - Principal Register
Mar 7, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 7, 2018
Notification Of Possible Opposition Sent To Ib
Feb 9, 2023
Teas Change Of Domestic Representatives Address
Mar 27, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 30, 2018
Notification Processed By Ib
Jun 12, 2018
Registered-Principal Register
Sep 12, 2018
Final Disposition Notice Created, To Be Sent To Ib
Sep 18, 2018
Final Disposition Processed
Sep 19, 2018
Final Disposition Notice Sent To Ib
Oct 6, 2018
Final Decision Transaction Processed By Ib
Feb 9, 2023
Teas Change Of Correspondence Received
Feb 9, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 9, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 13, 2023
Teas Change Of Domestic Representatives Address
Feb 9, 2023
Teas Change Of Owner Address Received
Feb 9, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 13, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 13, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 13, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 13, 2023
Teas Change Of Correspondence Received
Jun 4, 2023
New Representative At Ib Received
Jun 12, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 4, 2024
Teas Section 71 Received
Trademark Alertz updated from USPTO on 2030-01-24
